IN THIS
ISSUE
INTERVIEW WITH
BIODELIVERY SCIENCES’
PRESIDENT & CEO
MARK A. SIRGO
Intellectual
Property 22
Clifford M. Davidson, Esq.
Transdermal
Innovations 38
Cindy H. Dubin
Tyrosine-Derived
Polymers 48
Daniel J. Haders, PhD
FEATURING
Outsourcing
Trends 72
Barath Shankar
Marketing
Strategies 76
Malcolm A. Teasdale
The science & business of specialty pharma, biotechnology, and drug delivery
Nicholas C.
Nicolaides, PhD
Advancing Discovery
& Development of
Monoclonal Antibody
Therapeutics
Thomas
Franz, MD
30th Anniiversary of
the Franz Cellll Fiinite
Dose Model
Vishnu M. Patel, PhD
Mucoadhesive Bilayer
Buccal Tablets of
Propranolol Hydrochloride
Partnering With
Virionyx 78
Simon Wilkinson
Go to page 32
